BSAC
@bsacandjac
The British Society for Antimicrobial Chemotherapy
'Saving lives by fighting infection'
ID: 1174233288
http://www.bsac.org.uk 13-02-2013 07:33:00
9,9K Tweet
10,10K Takipçi
783 Takip Edilen
Comprehensive comparative analysis of the stability of cefiderocol & new β-lactam/β-lactamase inhibitor combinations for P. aeruginosa—promising data against this continuously evolving threat doi.org/10.1093/jac/dk… Jorge Arca Suárez German Bou @Luciagpinto OUP Medicine #JACNews
No neonatal and maternal side effects have been reported in this study suggesting a good tolerance valganciclovir for tertiary prevention: doi.org/10.1093/jac/dk… OUP Medicine Oxford Journals #JACNews
Save the date! The ever-popular two-day virtual conference jointly organised by BSAC and Global Antibiotic R&D Partnership (GARDP) is taking place on 4-5 February 2025, with Fiocruz and Cepid Aries as collaborating organisations. The outline programme and abstract submission details are now available.
A twice daily lamivudine dosing strategy for preterm infants from 24 to 37 week gestation: doi.org/10.1093/jac/dk… OUP Medicine Oxford Journals #JACNews
In this Letter to the Editor, Alexis Maillard et al. provide further data on the penetration of isavuconazole into the epithelial lining fluid in real-life patients with fungal lung infection: doi.org/10.1093/jac/dk… OUP Medicine Oxford Journals #JACNews
Vulnerable populations face inequalities in their access to healthcare. 🏥 Using a series of case studies, you can learn how to better support these patient groups and improve your practice in the future. 🤝 Sign up on FutureLearn 🖊️ ow.ly/RoE450KKhf4
The antibiotic emergency is a systemic risk that investors are tackling. Over 80 investors are calling for global action on AMR at the United Nations this month ft.com/content/b1c1e3… Investor Action on AMR FAIRR Initiative Access to Medicine Foundation
"When the drugs don't work." A new article, produced as part of Wounds that Won't Heal, BSAC's collaboration with The Bureau of Investigative Journalism, explores the lives of patients in Pakistan and Nigeria, where drugs are failing and deaths from drug-resistant infections are soaring. thebureauinvestigates.com/stories/2024-0…